Tempus AI (TEM) Projected to Post Earnings on Monday

Tempus AI (NASDAQ:TEM - Get Free Report) is anticipated to release its earnings data before the market opens on Monday, February 3rd. Analysts expect Tempus AI to post earnings of ($0.14) per share and revenue of $200.46 million for the quarter.

Tempus AI Stock Performance

TEM traded up $0.31 during trading on Tuesday, hitting $61.85. 15,655,270 shares of the company's stock were exchanged, compared to its average volume of 10,806,853. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $79.49. The business's 50 day moving average is $44.20 and its two-hundred day moving average is $48.58. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Insider Buying and Selling

In other Tempus AI news, CEO Eric P. Lefkofsky sold 82,056 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $58.21, for a total transaction of $4,776,479.76. Following the sale, the chief executive officer now owns 5,532,987 shares in the company, valued at $322,075,173.27. This represents a 1.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the firm's stock in a transaction on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the transaction, the chief accounting officer now directly owns 57,237 shares of the company's stock, valued at $3,434,220. The trade was a 19.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 2,037,702 shares of company stock valued at $89,449,651.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on TEM. Guggenheim assumed coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a "buy" rating and a $74.00 target price on the stock. Loop Capital dropped their target price on Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a report on Tuesday, January 14th. Stifel Nicolaus cut Tempus AI from a "buy" rating to a "hold" rating and lifted their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Wolfe Research assumed coverage on Tempus AI in a research report on Friday, December 13th. They issued an "outperform" rating and a $60.00 price target for the company. Finally, Bank of America lifted their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a report on Friday, December 13th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $56.36.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.